Stock Market & Financial Investment News

News Breaks February 20, 2013 09:13 EDT THLD Threshold Pharmaceuticals upgraded to Overweight from Neutral at Piper Jaffray Piprer Jaffray upgraded Threshold Pharmaceuticals citing its TH-302 opportunity. Price target raised to $10 from $5. News For THLD From The Last 14 Days Check below for free stories on THLD the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for THLD Sign up for a free trial to see the rest of the stories you've been missing.